The NOP2 rs3764909 and NSUN4 rs10252 variants enhanced the risk of acute lymphoblastic leukemia in children and are considered potential biomarkers of pediatric acute lymphoblastic leukemia [89]. This evidence concerns the gene NOP2 and acute lymphoblastic leukemia.